Scandinavian Journal of Gastroenterology · 2004 · 43 citations · 26 references
MedicineInfectious DiseasesPathologyDiagnostic MicrobiologyGastroenterologyMedical MicrobiologyGastric DiseasesGastric DisordersGastrointestinal DiseaseGastrointestinal InfectionsGastrointestinal PathologyHelicobacter Pylori Eradication TherapyAntigen Detection In StoolAntigen Detection TestsEradicationHelicobacter Pylori EradicationHelicobacter Pylori InfectionMonoclonal Antibody-based AssaysStool Antigen TestUrea Breath Test
BACKGROUND: Recent availability of tests for Helicobacter pylori antigens in stool samples has provided potentially useful tools for epidemiological studies and clinical settings. The aim of this study was to evaluate a monoclonal antibody-based H. pylori antigen stool test in the primary diagnosis of H. pylori infection, and to study the test performance after patients were treated with lanzoprazole, and after eradication therapy. METHODS: The study included 122 dyspeptic patients. At gastroscopy, biopsy specimens were obtained for culture and histology. Stool antigen and [14C]-urea breath tests were performed concurrently. Positive culture alone or a positive [14C]-urea breath test in combination with positive histology defined the reference standard. Forty-three Hp +ve patients were treated with lanzoprazole for 2 to 4 weeks, and stool antigen tests were performed on days 1 and 7 post-treatment. After eradication therapy, 32 patients were re-examined for H. pylori infection. RESULTS: Prevalence of H. pylori was 44.3%. Sensitivity and specificity for the stool antigen test in the primary diagnosis of H. pylori infection were 98% and 94%, with positive and negative likelihood ratios of 16.7 and 0.02, respectively. All patients had positive stool tests immediately after lanzoprazole treatment, whereas 2 patients had negative stool tests after 7 days. Triple therapy rendered all patients stool test negative. CONCLUSIONS: The monoclonal antibody-based stool antigen test is an accurate tool in the primary diagnosis of H. pylori infection and after eradication therapy. Lanzoprazole treatment does not influence the clinical performance of the test.
26
<i>Helicobacter pylori</i> Infection and the Development of Gastric Cancer
Naomi Uemura, Shiro Okamoto, Soichiro Yamamoto et al. · New England Journal of Medicine · 2001 · 4.5K citations · Full text
Medicine, Microbiology, Oncology +15
Helicobacter pylori Eradication to Prevent Gastric Cancer in a High-Risk Region of China
Benjamin Chun–Yu Wong, Shiu Kum Lam, Wai Man Wong et al. · JAMA · 2004 · 1.4K citations
Antoine de Mascarel, Anne Marie Sarrasqueta, Bernard Bergey et al. · The American Journal of Gastroenterology · 2001 · 184 citations